| Net Cash Provided by (Used in) Operating Activities |
$3,090,000,000 |
USD |
70% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$5,229,000,000 |
USD |
-291% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$485,000,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
100,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
91,500 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,654,000,000 |
USD |
42% |
Q2 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$1,217,000,000 |
USD |
10% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$1,031,000,000 |
USD |
2.6% |
Q1 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$2,414,000,000 |
USD |
57% |
Q4 2025 |
Q3 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$262,000,000 |
USD |
111% |
Q4 2025 |
Q3 2026 |
| Unrecognized Tax Benefits |
$63,000,000 |
USD |
21% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,031,000,000 |
USD |
2.7% |
Q1 2025 |
FY 2025 |
| Interest Expense |
$5,555,000,000 |
USD |
-3.3% |
Q4 2025 |
Q3 2026 |